Efficacy evaluation of adalimumab (HUMIRA (R)) by dose and administration route of concomitant methotrexate in widespread clinical practice (react trial)

Bombardieri, S; Tzioufas, AG; McKenna, F; Beat, MA; Spencer-Green, GT; Kupper, H

dc.contributor.author	Bombardieri, S	en
dc.contributor.author	Tzioufas, AG	en
dc.contributor.author	McKenna, F	en
dc.contributor.author	Beat, MA	en
dc.contributor.author	Spencer-Green, GT	en
dc.contributor.author	Kupper, H	en
dc.date.accessioned	2014-03-01T11:45:55Z
dc.date.available	2014-03-01T11:45:55Z
dc.date.issued	2005	en
dc.identifier.issn	0003-4967	en
dc.identifier.uri	https://dspace.lib.ntua.gr/xmlui/handle/123456789/37702
dc.subject.classification	Rheumatology	en
dc.title	Efficacy evaluation of adalimumab (HUMIRA (R)) by dose and administration route of concomitant methotrexate in widespread clinical practice (react trial)	en
heal.type	other	en
heal.language	English	en
heal.publicationDate	2005	en
heal.publisher	B M J PUBLISHING GROUP	en
heal.journalName	ANNALS OF THE RHEUMATIC DISEASES	en
dc.identifier.isi	ISI:000229909102084	en
dc.identifier.volume	64	en
dc.identifier.spage	428	en
dc.identifier.epage	428	en